Zoetis Inc Cl A(ZTS-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low78.45
Day High79.65
Open:78.85
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Phibro Animal Health (PAHC) and Zoetis (ZTS)
Stock Target Advisor
US Analyst Updates: October 16th, 2026
US Analyst Updates: October 16th, 2026
StockStory
3 Reasons ZTS is Risky and 1 Stock to Buy Instead
ZTS
Tipranks
Zoetis Appoints Iris Knobloch to Board of Directors
StockStory
Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers
ZTS
Tipranks
Zoetis Declares Fourth-Quarter Dividend, Signals Ongoing Strength
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Eli Lilly & Co (LLY) and Liquidia Technologies (LQDA)
StockStory
1 Mid-Cap Stock with Exciting Potential and 2 We Turn Down
GGG
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Dexcom (DXCM) and Alnylam Pharma (ALNY)
SYNDTGAM
Why this money manager bought UnitedHealth, Palantir and sold Zoetis
illustration of Paul Harris for The Mover.. May 7, 2022. Illustration by Jacqueline Oakley
StockStory
1 Oversold Stock Ready to Bounce Back and 2 Facing Challenges
SMPL
Tipranks
TD Cowen Sticks to Their Buy Rating for Zoetis (ZTS)
StockStory
3 of Wall Street’s Favorite Stocks We’re Skeptical Of
NXPI
StockStory
The Top 5 Analyst Questions From Zoetis’s Q2 Earnings Call
ZTS
StockStory
2 Large-Cap Stocks for Long-Term Investors and 1 We Avoid
ZTS
Tipranks
Zoetis Earnings Call Reveals Growth Amid Headwinds
Tipranks
Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Celldex (CLDX)
Tipranks
Zoetis Appoints Jay Saccaro as Executive Finance Leader
Tipranks
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Protagonist Therapeutics (PTGX) and Zoetis (ZTS)

Profile

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Market data provided by Barchart. Exchange delay details and data provider terms here. Information may be delayed, is provided 'as is' and is solely for informational purposes, and not for trading, investment or advice.